Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 1, 1997, Pages 7-15

  Geter Douglass, Beth ^a,b   Katz, Jonathan L ^a   Alling, Ken ^a   Acri, Jane B ^a   Witkin, Jeffrey M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NIDA Addiction Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; APOMORPHINE; BROMOCRIPTINE; COCAINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CLIMBING; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG EFFECT; DRUG SCREENING; GNAWING; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCRATCHING; SQUIRREL MONKEY;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE AGONISTS; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 0030867844     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. 3, receptor ligands. Eur. J. Pharmacol. 281: R7-R9, 1995.
2. 3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat. Eur. J. Pharmacol. 260: 177-181, 1994.
3. 1 receptor efficacy. Eur. J. Pharmacol. 188: 335-347, 1990.
4. 2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmacol. Toxicol. 62: 121-130, 1988.
5. ARNT, J., HYTTEL, J. AND PERREGAARD, J.: Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur. J. Pharmacol. 133: 137-145, 1987.
6. BAKER, L. E., RIDDLE, E. E., SAUNDERS, R. B. AND APPEL, J. B.: The role of monoamine uptake in the discriminative stimulus properties of cocaine and related compounds. Behav. Pharmacol. 4: 69-79, 1993.
7. BRISTOW, L. J., COOK, G. P., GAY, J. C., KULAGOWSKI, J. J., LANDON, L., MURRAY, F., SAYWELL, K. L., YOUNG, L. AND HUTSON, P. H.: The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat. Neuropharmacology 35: 285-294, 1996.
8. 3 dopamine receptors. Neuropsychopharmacology 12: 335-345, 1995.
9. 3 dopamine receptors. Science 260: 1814-1816, 1993.
10. CAINE, S. B. AND KOOB, G. F.: Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self -administration dose-effect function to the left under different schedules in the rat. Behav. Pharmacol. 6: 333-347, 1995.
11. CHIO, C. L., LAJINESS, M. E. AND HUFF, R. M.: Activation of heterologously expressed D3 dopamine receptors: Comparison to D2 dopamine receptors. Mol. Pharmacol. 45: 51-60, 1994.
12. 2 dopamine receptor classification and its functional implications. Synapse 1: 347-388, 1987.
13. DALY, S. A. AND WADDINGTON, J. L.: D-1 dopamine receptors and the topography of unconditioned motor behaviour: Studies with the selective, "full efficacy" benzazepine D-1 agonist SKF 83189. J. Psychopharmacol. 6: 50-60, 1992.
14. DALY, S. A. AND WADDINGTON, J. L.: Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists. Neuropharmacology 32: 509-510, 1993.
15. 3 receptor ligand. Eur. J. Pharmacol., 249: R9-R10, 1993.
16. 3 receptor agonist 7-OH-DPAT: Comparison with quinpirole and apomorphine. Psychopharmacology 124: 231-240, 1996.
17. 1-like" dopamine receptors not linked to adenylyl cyclase. Br. J. Pharmacol. 116: 2120-2126, 1995.
18. EILAM, D. AND SZECHTMAN, H.: Biphasic effects of the D-2 agonist quinpirole on locomotion and movements. Eur. J. Pharmacol. 161: 151-157, 1989.
19. 3 dopamine receptor. J. Pharm. Exp. Ther. 268: 417-426, 1994.
20. FRENCH, D. AND WITKIN, J. M.: Effects of the dopamine release inhibitor, CGS 10746B, on the locomotor stimulant and discriminative stimulus effects of cocaine and methamphetamine. Pharmacol. Biochem Behav. 46: 989-993, 1993.
21. JACKSON, D. M. AND WESTLIND-DANIELSSON, A.: Dopamine receptors: Molecular biology, biochemistry and behavioral aspects. Pharmacol. Ther. 64: 291-369, 1994.
22. JOHANSON, C-E. AND FISCHMAN, M. W.: The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41: 3-52, 1989.
23. KEBABIAN, J. W. AND CALNE, D. B.: Multiple receptors for dopamine. Nature 277: 93-96, 1979.
24. KELLEY, A. E. AND LANG, C. G.: Effects of GBR 12909, a selective dopamine uptake inhibitor, on a motor activity and operant behavior in the rat. Eur. J. Pharmacol. 167: 385-395, 1989.
25. KUHAR, M. J., RITZ, M. C. AND BOJA, J. W.: The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14: 299-302, 1991.
26. LITCHFIELD, J. T. AND WILCOXON, F.: A simplified method of evaluating dose-effect responses. J. Pharmacol. Exp. Ther. 95: 99-113, 1949.
27. LONGONI, R., SPINA, L. AND DI CHIARA, G.: Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats. Eur. J. Pharmacol. 134: 163-173, 1987.
28. 3 receptors: Effects of ions and guanine nucleotides. J. Pharmacol. Exp. Ther. 274: 790-797, 1995.
29. MARTIN, G. E. AND BENDESKY, R. J.: Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation. J. Pharmacol. Exp. Ther. 229: 706-711, 1984.
30. MARTIN, G. E., WILLIAMS, M., PETTIBONE, D. J., YARBOROUGH, G. G., CLINESCHMIDT, B. V. AND JONES, J. H.: Pharmacological profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO]. J. Pharmacol. Exp. Ther. 230: 569-576, 1984.
31. 3 selective receptor ligand. Soc. Neurosci. Abstr. 19: 1064, 1993.
32. 3 receptors. Eur. J. Pharmacol. 249, R5-R6, 1993.
33. 3 receptors, blocks 7-OH-DPAT-induced hyperthermia in rats. Eur. J. Pharmacol. 260: R3-R5, 1994.
34. 2 agonist RU 24213. Eur J. Pharmacol., 116: 183-186, 1985.
35. 2 receptor activation. Psychopharmacology 94: 263-266, 1988.
36. 2 interaction. Eur. J. Pharmacol. 160: 377-384, 1989.
37. 1 dopamine receptor. Neuropharmacology 28: 401-405, 1989.
38. PIERCE, R. C. AND REBEC, G. V.: Stimulation of both D1 and D2 dopamine receptors increase behavioral activation and ascorbate release in the neostriatum of freely moving rats. Eur. J. Pharmacol. 191: 295-302, 1990.
39. 2 agonists in squirrel monkeys. J. Pharmacol. Exp. Ther. 273: 138-145, 1995.
40. 2 dopamine receptor systems. Pharmacol. Biochem Behav. 36: 327-331, 1990.
41. 3 agonist PD 128,907. J. Pharmacol. Exp. Ther. 275: 1355-1366, 1995.
42. RIVET, J-M., AUDINOT, V., GOBERT, A., PEGLION, J-L. AND MILLAN, M. J.: Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297. Eur. J. Pharmacol. 365: 175-177, 1994.
43. RODRÍGUEZ DE FONSECA, F., RUBIO, P., MARTÍN-CALDERÓN, J. L., CAINE, S. B., KOOB, G. F. AND NAVARRO, M.: The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur. J. Pharmacol. 274: 47-55, 1995.
44. 1 stimulation. Life Sci. 33: 2479-2483, 1983.
45. 2 agonist (+)-4-propyl-9-hydroxynapthoxazine by dopamine antagonists in monkeys. J. Pharmacol. Exp. Ther. 265: 1039-1046, 1993.
46. 2 agonists in squirrel monkeys. Psychopharmacology 116: 9-18, 1994.
47. SEEMAN, P.: Dopamine receptors and psychosis. Sci. Am. Sci. Med. 28-37, September/October 1995.
48. SEEMAN, P. AND VAN TOL, H. M.: Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15: 264-279, 1994.
49. SIBLEY, D. R. AND MONSMA, F. J.: Molecular Biology of dopamine receptors. Trends Pharmacol. Sci. 13: 61-69, 1992.
50. 2 receptor. Eur. J. Pharmacol. 225: 331-337, 1992.
51. 3) as a target for neuroleptics. Nature 347: 146-151, 1990.
52. SPEALMAN, R.: Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp Ther. 278: 1128-1137, 1996.
53. SPEALMAN, R. D., BERGMAN, J., MADRAS, B. K. AND MELIA, K. F.: Discriminative stimulus effects of cocaine in squirrel monkeys: Involvement of dopamine receptor subtypes. J. Pharmacol. Exp. Ther. 258: 945-953, 1991.
54. 3 receptors. Eur. J. Pharmacol. 277: 151-158, 1995.
55. 3 receptors. Eur. J. Pharmacol. 263: 235-243, 1994.
56. 1 agonist SKF 38393 and their attenuation in non-habituated mice. Psychopharmacology 110: 69-75, 1993.
57. TIRELLI, E. AND WITKIN, J. M.: Verticalization of behavior elicited by dopaminergic mobilization is quantitatively different between C57BL/6J and DBA/2J mice. Psychopharmacology 116: 191-200, 1994a.
58. TIRELLI, E. AND WITKIN, J. M.: Transient hypersensitivity to apomorphine-induced gnawing after termination of acute effects of a single high dose of cocaine. Behav. Pharmacol. 5: 289-298, 1994b.
59. TIRELLI, E. AND WITKIN, J. M.: Differential effects of direct and indirect dopamine agonists on the induction of gnawing in C57B I/6J mice. J. Pharmacol. Exp. Ther. 273: 7-15, 1995.
60. WATERS, N., SVENSSON, K., HAADSMA-SVENSSON, S. R., SMITH, M. W. AND CARLSSON, A.: The dopamine D-3 receptor: A postsynaptic receptor inhibitory on rat locomotor behavior. J. Neural Transm. 94: 11-19, 1993.
61. WITKIN, J. M.: Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists. Life Sci. 53: PL 405-410, 1993.
62. WITKIN, J. M.: Pharmacotherapy of cocaine abuse: Preclinical development. Neurosci. Biobehav. Rev. 18: 121-142, 1994.
63. 3 ligands: I. Dimeric 2-[4[(3-aminopropoxy)phenyl] benzimidazole antagonists. Bioorganic Med. Chem. Lett. 5: 2541-2546, 1995.
64. 1 dopamine receptors. Eur. J. Pharmacol. 148: 221-229, 1988.